» Articles » PMID: 39346594

Risk Factors for Cognitive Dysfunction Amongst Patients with Cardiovascular Diseases

Overview
Specialty Public Health
Date 2024 Sep 30
PMID 39346594
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney disease and depressive symptoms on cognition.

Methods: A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: preserved cognition, mild, and advanced cognitive dysfunction (CD). Data were analyzed using Cronbach alpha (Cα) and McDonald's ω (Mω) for internal consistency. The Chi-square test, Cramer's V test, and correlation analyses were also applied.

Results: Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression and the severity of CD ( = 0.25,  = 0.0001). A weak association between CD and female gender ( = 0.016), atrial fibrillation ( = 0.03), stroke ( = 0.009), and a moderate association for age group ( < 0.0001), education level ( < 0.0001), smoking ( < 0.0001), and renal dysfunction ( < 0.0001) was found. Age ≥ 70 years, eGFR 30-59 mL/min/1.73m significantly increased the likelihood for mild and advanced CD, while smoking and > 9 classes decreased it. Female gender, history of atrial fibrillation, and stroke significantly increased the likelihood of advanced CD.

Conclusion: Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gender, previous diagnosis of atrial fibrillation, and stroke are risk factors for advanced CD.

References
1.
Hua J, Dong J, Chen G, Shen Y . Trends in cognitive function before and after stroke in China. BMC Med. 2023; 21(1):204. PMC: 10242976. DOI: 10.1186/s12916-023-02908-5. View

2.
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D . European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022; 43(8):716-799. DOI: 10.1093/eurheartj/ehab892. View

3.
Knopman D, Gottesman R, Sharrett A, Tapia A, DavisThomas S, Windham B . Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study. Alzheimers Dement. 2018; 14(11):1406-1415. PMC: 6231996. DOI: 10.1016/j.jalz.2018.03.011. View

4.
Ismail Z, Elbayoumi H, Fischer C, Hogan D, Millikin C, Schweizer T . Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2016; 74(1):58-67. DOI: 10.1001/jamapsychiatry.2016.3162. View

5.
Kurella Tamura M, Wadley V, Yaffe K, McClure L, Howard G, Go R . Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008; 52(2):227-34. PMC: 2593146. DOI: 10.1053/j.ajkd.2008.05.004. View